Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Term Cardiovascular and Renal Effects of Moringa Oleifera Extracts and Stevia Rebaudiana Bertoni as add-on Therapy in a Population of Type II Diabetes Individuals

NCT04254029 is registered in ClinicalTrials.gov with Yaounde Central Hospital as lead sponsor.

NCT NCT04254029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04254029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Term Cardiovascular and Renal Effects of Moringa Oleifera Extracts and Stevia Rebaudiana Bertoni as add-on Therapy in a Population of Type II Diabetes Individuals
Lead sponsor
Yaounde Central Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2016
Completion date
May 1, 2017
Enrollment
19 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benefits of a capsules of moringa oleifera and stevia rebaudiana bertoni in patients with type 2 diabetes mellitus before and after 45 days of add-on therapy